Creating solutions, not products, in diabetes

Roche Diabetes Care’s Michael Goetzl explains how the company is spearheading a combined digital-pharmaceutical approach to diabetes and how pharma firms can best embrace holistic strategie

Lilly and Boehringer rejig diabetes alliance as Jardiance so...

Eli Lilly and Boehringer Ingelheim have changed the terms of their diabetes alliance to focus their energies on developing their big-selling Jardiance pill.

Sanofi builds case for Toujeo in younger type 1 diabetics

FDA approves AZ's Farxiga in new heart failure prevention us...

The FDA has approved AstraZeneca’s diabetes drug Farxiga to reduce the chances of hospitalisations for heart failure in adults with type 2 diabetes and other cardiovascular risks.<

CHMP backs Lilly’s Baqsimi as non-injectable for severe low ...

Artificial pancreas outperforms current tech in type 1 diabe...

An “artificial pancreas” has proved to be more effective at controlling blood sugar than injections with insulin by patients or with a pump, in an international trial mainly funded by the U